Trial · NCT06666933
Study of Time-restricted Eating (TRE) to Clinical Pregnancy Rate in PCOS Women With Glucose Metabolism Disorder Via IVF/ICSI
NCT06666933, Not applicable, Unknown, RenJi Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of Time-restricted Eating (TRE) to Clinical Pregnancy Rate in PCOS Women With Glucose Metabolism Disorder Via IVF/ICSI. Trials, record NCT06666933. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06666933
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of Time-restricted Eating (TRE) to Clinical Pregnancy Rate in PCOS Women With Glucose Metabolism Disorder Via IVF/ICSI
- NCT number
- NCT06666933
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 254 participants, estimated
- Lead sponsor
- RenJi Hospital
- Conditions
- PCOS, Glucose Metabolism Disorder, IVF Outcome
- Interventions
- Time restricted eating, Metformin
- First posted
- 2024-10-31
- Last updated
- 2024-10-31
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical pregnancy rate for the first embryo transfer | 4-5 weeks after the IVF/ ICSI carried out at the end of the 6 weeks intervention | Clinical pregnancy rate= (number of cycle for 1or more gestational sac is observed via transvaginal ultrasound/ total number of cycle for first embryo transfer)x100% |
| Secondary | Number of retrieved oocytes | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | Includes immature oocytes, mature oocytes and abnormal oocytes from ovum pick-up |
| Secondary | Implantation rate | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | the ration of total number of early gestational sacs to total number of transferred embryos |
| Secondary | Abortion rate | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | the ratio of the number of nonviable pregnancies before 28 weeks of gestation to the number of clinical pregnancies |
| Secondary | Number of good quality embryo | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | Day 3 embryo with 7-9 cells and \<10% fragmentation |
| Secondary | Weight | From enrollment to the end of treatment at 6 weeks | Weight change in kg |
| Secondary | Fat% | From enrollment to the end of treatment at 6 weeks | Inbody machine measurement |
| Secondary | Lipid profile | From enrollment to the end of treatment at 6 weeks | Triglycerol, total cholesterol, HDL, LDL, free fatty acid in mmol/L |
| Secondary | Blood pressure | From enrollment to the end of treatment at 6 weeks | Both systolic and diastolic pressure in mmHg |
| Secondary | Sex hormone | From enrollment to the end of treatment at 6 weeks | DHEAs, testosterone, androstadienone, estradiol, LH, FSH, progesterone, prolactin, SHBG |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06666933
GET https://conductscience.org/api/trials/v1/NCT06666933/registered